Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
97
TGA:97
Drug Approvals
FRUZAQLA fruquintinib 1 mg hard capsule bottle (422039)
- Product Name
- FRUZAQLA fruquintinib 1 mg hard capsule bottle
- Approval Date
- Oct 1, 2024
TGA
FRUZAQLA fruquintinib 5 mg hard capsule bottle (422038)
- Product Name
- FRUZAQLA fruquintinib 5 mg hard capsule bottle
- Approval Date
- Oct 1, 2024
TGA
TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe (409942)
- Product Name
- TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe
- Approval Date
- Jul 25, 2024
TGA
Guanfacine 1 TAKEDA, guanfacine (as hydrochloride) 1 mg modified release tablet blister pack (395368)
- Product Name
- Guanfacine 1 TAKEDA, guanfacine (as hydrochloride) 1 mg modified release tablet blister pack
- Approval Date
- Dec 2, 2022
TGA
Guanfacine 2 TAKEDA, guanfacine (as hydrochloride) 2 mg modified release tablet blister pack (395369)
- Product Name
- Guanfacine 2 TAKEDA, guanfacine (as hydrochloride) 2 mg modified release tablet blister pack
- Approval Date
- Dec 2, 2022
TGA
Guanfacine 4 TAKEDA, guanfacine (as hydrochloride) 4 mg modified release tablet blister pack (395374)
- Product Name
- Guanfacine 4 TAKEDA, guanfacine (as hydrochloride) 4 mg modified release tablet blister pack
- Approval Date
- Dec 2, 2022
TGA
Guanfacine 3 TAKEDA, guanfacine (as hydrochloride) 3 mg modified release tablet blister pack (395373)
- Product Name
- Guanfacine 3 TAKEDA, guanfacine (as hydrochloride) 3 mg modified release tablet blister pack
- Approval Date
- Dec 2, 2022
TGA
LIVTENCITY maribavir 200 mg film coated tablet bottle (380132)
- Product Name
- LIVTENCITY maribavir 200 mg film coated tablet bottle
- Approval Date
- Oct 7, 2022
TGA
ICLUSIG ponatinib (as hydrochloride) 10 mg film-coated tablet bottle (374484)
- Product Name
- ICLUSIG ponatinib (as hydrochloride) 10 mg film-coated tablet bottle
- Approval Date
- Sep 16, 2022
TGA
ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle (374492)
- Product Name
- ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle
- Approval Date
- Sep 16, 2022
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found